Published in Pharma Law Weekly, June 15th, 2010
"The analysis of the Phase I and II data presented at ASCO helped to provide the basis for the ongoing global Phase III clinical trial of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.